Eaat4 Protein (Excitatory Amino Acid Transporter 4) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Eaat4 Protein (Excitatory Amino Acid Transporter 4) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
EAAT4
| Protein Name | EAAT4 |
| Gene | SLC1A6 |
| UniProt ID | P22732 |
| Molecular Weight | ~65 kDa |
| Subcellular Localization | Plasma membrane (neurons) |
| Protein Family | SLC1 (EAAT) family |
| Associated Diseases | Epilepsy, Ataxia, Neurodegeneration |
EAAT4 is a transmembrane protein with:
The transporter has a "transport gate" mechanism where the substrate binding site is alternately exposed to the extracellular and intracellular sides. EAAT4 contains ankyrin-binding motifs in its C-terminal domain, allowing association with the cytoskeleton.
EAAT4 is a high-affinity glutamate transporter that:
Glutamate clearance: Removes glutamate from the extracellular space with high affinity (Km ~10 μM), preventing excitotoxic accumulation.
Sodium coupling: Cotransports 3 Na+ and 1 H+ with each glutamate, countertransporting 1 K+. This electrogenic process contributes to the resting membrane potential.
Anion channel activity: Unlike other EAATs, EAAT4 exhibits significant chloride conductance when activated, which may modulate neuronal excitability.
Spatial buffering: In Purkinje cells, EAAT4 helps buffer extracellular glutamate during parallel fiber-Purkinje cell synaptic transmission, shaping cerebellar plasticity.
EAAT4's unique properties make it crucial for:
EAAT4 dysfunction contributes to neurological disorders:
Ataxia:
Epilepsy:
Neurodegeneration:
Ischemia:
Therapeutic strategies for EAAT4:
Positive allosteric modulators: Enhance EAAT4 transporter function to increase glutamate clearance.
Gene therapy: AAV-mediated EAAT4 overexpression in cerebellar neurons.
Sodium channel modulators: Since EAAT4 is sodium-dependent, modulating sodium channels can indirectly affect glutamate transport.
Anti-epileptic drugs: Some AEDs may act partly through enhancing EAAT function.
Neuroprotective strategies: Targeting downstream excitotoxic pathways when EAAT4 function is compromised.
Eaat4 Protein (Excitatory Amino Acid Transporter 4) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Eaat4 Protein (Excitatory Amino Acid Transporter 4) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.